Results 71 to 80 of about 16,296 (194)
Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histocytosis and Erdheim-Chester disease [PDF]
, 2017 Erdheim–Chester disease (ECD) is a rare histiocytic disorder, characterized by the xanthomatous infiltration of tissues by CD68-positive and CD1a-/CD100-negative foamy histiocytes. In childhood, ECD is exceptionally rare, and only a dozen cases have been
Bánusz, Rita +6 more
core +2 more sources
مجله دانشکده پزشکی اصفهان, 2010 Background: Patients with Langerhans cell histiocytosis are at particularly high risk for central diabetes insipi-dus (CDI) due to hypothalamic-pituitary disease. Langerhans cell histiocytosis (LCH) is a group of idiopathic disorders characterized by the
Zahra Alian +2 more
doaj
A rare case of "switch on and off" multi-system Langerhans cell histiocytosis in an adult patient
Journal of Medical Case Reports, 2011 Introduction We report the case of a 24-year-old Greek woman with histologically proven osseous and pulmonary Langerhans cell histiocytosis whose lesions had progressively regressed with a "switch on and off" mode.
Froudarakis Marios E +2 more
doaj +1 more source
Clinical and Translational Science, Volume 18, Issue 5, May 2025.ABSTRACT Pharmacogenomics remains underutilized in pediatric oncology, despite the existence of evidence‐based guidelines. Implementation of pharmacogenomics‐informed prescribing could improve medication safety and efficacy in pediatric oncology patients, who are at high risk of adverse drug reactions.
Claire Moore +8 more
wiley +1 more source
BRAF V600E-Positive Multisite Langerhans Cell Histiocytosis in a Preterm Neonate [PDF]
, 2013 Hemorrhagic pustules with a “blueberry muffin” appearance accompanied by respiratory failure in a neonate present a challenging differential diagnosis that includes infections and neoplasms.
Aslam, Muhammad +8 more
core +3 more sources
Bengal Journal of Otolaryngology and Head Neck Surgery, 2017 Introduction A case of Langerhans cell histiocytosis (LGH) involving extensive area of base of skull resulting in panhypopituitarism and diabetes insipidus (DI) is reported.
Anirban Ghosh +2 more
doaj +3 more sources
Late-Onset Langerhans Cell Histiocytosis Presenting with Seizures and Bilateral Temporal Involvement
Archives of Epilepsy, 2022 Langerhans cell histiocytosis is known as a rare childhood disease. In this case, we wanted to share our patient’s experience whose first symptom was an epileptic seizure, which attracted attention at an advanced age and revealed bilateral temporal lobe ...
Özge Öcek, Hasan Kuş, Pınar Ortan
doaj +1 more source
ACR Open Rheumatology, Volume 7, Issue 4, April 2025.A middle‐aged woman presented with a granulomatous breast lesion in 2018. By 2021, antibiotic‐resistant pneumonia led to the discovery of granulomatous inflammation in the lung and thyroid. Initially misdiagnosed as Erdheim–Chester disease (ECD), she was treated with interferon without success.
Benedetta Fazzi +4 more
wiley +1 more source
Measuring diffuse metabolic activity on FDG-PET/CT: new method for evaluating Langerhans cell histiocytosis activity in pulmonary parenchyma [PDF]
, 2012 Pulmonary Langerhans cell histiocytosis (PLCH) is a rare cause of interstitial lung disease characterized by formation of nodules in the active phase of the disease that evolve into nonactive cystic lesions later on. To evaluate PLCH activity in patients,
Colby +30 more
core +1 more source
CASE OF GUILLAIN-BARRE´ SYNDROME IN A PATIENT WITH PULMONARY LANGERHANS CELL HYSTIOCYTOSIS
Архивъ внутренней медицины, 2019 Langerhans cell histiocytosis is a rare disease characterized by various clinical patterns: from isolated lung lesions to severe involvement of other organs.
E. V. Efremova +5 more
doaj +1 more source